BioMérieux S.A.
BIM
Peringkat dalam Saham
#1761
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Harga Saham
$103.91
Kapitalisasi Pasar
$12.23B
Perubahan (1 hari)
0.86%
Perubahan (1 tahun)
-19.74%
Negara
FR
Perdagangan BioMérieux S.A. (BIM)
Kategori
Healthcare
Laba untuk BioMérieux S.A. (BIM)
Laba pada Jun 2026 TTM: $720.00M
Menurut laporan keuangan terbaru dari BioMérieux S.A., laba saat ini perusahaan adalah $720.00M. Pada tahun 2023, perusahaan memperoleh laba sebesar $483.64M, penurunan dibandingkan dengan laba tahun 2022 sebesar $590.19M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk BioMérieux S.A. dari 2005 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $720.00M | 19.44% |
| 2024 | $602.80M | 24.64% |
| 2023 | $483.64M | -18.05% |
| 2022 | $590.19M | -30.64% |
| 2021 | $850.93M | 41.32% |
| 2020 | $602.12M | 68.44% |
| 2019 | $357.47M | -2.94% |
| 2018 | $368.30M | 5.12% |
| 2017 | $350.37M | 28.57% |
| 2016 | $272.52M | 42.44% |
| 2015 | $191.32M | -15.53% |
| 2014 | $226.50M | -32.25% |
| 2013 | $334.30M | 13.34% |
| 2012 | $294.95M | -4.15% |
| 2011 | $307.71M | -4.66% |
| 2010 | $322.75M | 11.10% |
| 2009 | $290.50M | 14.03% |
| 2008 | $254.76M | 12.73% |
| 2007 | $225.98M | 12.99% |
| 2006 | $200.00M | 22.21% |
| 2005 | $163.65M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $7.61B | 956.81% |
US
|
|
| $4.76B | 561.39% |
US
|
|
| $-252.70M | -135.10% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 130.28% |
US
|
